SYNAIRGEN Aktie

 >SYNAIRGEN Aktienkurs 
2.08 EUR    +5.6%    (Tradegate)
Ask: 2.06 EUR / 774 Stück
Bid: 1.99 EUR / 806 Stück
Tagesumsatz: 2780 Stück
Realtime Kurs von 8 bis 22 Uhr!
>SYNAIRGEN Performance
1 Woche: -4,0%
1 Monat: +2,1%
3 Monate: -21,8%
6 Monate: +167,6%
1 Jahr: 0%
laufendes Jahr: 0%
>SYNAIRGEN Aktie
Name:  SYNAIRGEN PLC LS-,01
Land:  Großbritannien
Sektor:  Gesundheit
ISIN/ Wkn:  GB00B0381Z20 / A0DK7J
Symbol/ Ticker:  OMY (Frankfurt)
Kürzel:  FRA:OMY, OMY.F, OMY:GR
Index:  -
Webseite:  https://www.synairgen.com..
Marktkapitalisierung:  314.54 Mio. EUR
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  699.73 / 25.07 / -
Gewinnm./ Eigenkapitalr.:  - / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Suchwörter:  SYNAIRGEN
Letzte Datenerhebung:  23.10.20
>SYNAIRGEN Eigentümer
Aktien: -
f.h. Aktien: -
Insider Eigner: -
Instit. Eigner: -
Leerverk. Aktien: -
>SYNAIRGEN Peer Group

 
20.10.20 - 07:26
Director Deals - Synairgen PLC (SNG) (StockMarketWire)
 
John Ward, Executive Director, exercised 147,330 shares in the company on the 19th October 2020 at a price of £1.75. The Director now holds 514,907 shares. Story provided by StockMarketWire.com Director deals data provided by www.sharesmagazine.co.u...
20.10.20 - 07:20
Director Deals - Synairgen PLC (SNG) (StockMarketWire)
 
Richard Marsden, Chief Executive Officer, exercised 386,842 shares in the company on the 19th October 2020 at a price of £1.75. The Director now holds 754,667 shares. Story provided by StockMarketWire.com Director deals data provided by www.sharesma...
17.10.20 - 11:07
Small Cap Movers: ′Ten-baggers′ Synairgen, Alien Metals keep up impressive share price runs (Proactive Investors)
 
Synairgen PLC (LON:SNG) this week completed an £80mln share placing to support its lead drug through final-stage coronavirus (COVID-19) clinical trials. Nothing unusual there - except for the fact that a year ago the business was valued at just ove...
16.10.20 - 17:52
SMALL CAP MOVERS: ′Ten-baggers′ Synairgen and Alien Metals keep up with impressive share price run (DailyMail)
 
Synairgen this week completed an £80 million share placing to support its lead drug through final-stage COVID-19 clinical trials. Its shares have zoomed up 2,082 per cent to 194p in twelve months....
16.10.20 - 15:13
Synairgen gets house broker upgrade after impressive fundraise (Proactive Investors)
 
House broker finnCap has raised its price target on Synairgen PLC to 420p (LON:SNG) following its fundraise and managed access programme with Clinigen.   Synairgen this week raised £80mln to fund a Phase III trial for its candidate SNG001 in COVID...
16.10.20 - 06:28
XFRA : INSTRUMENT_EVENT EQUBF_01 (XETRA)
 
CAPITAL ADJUSTMENT INFORMATION - 16.10.2020;Das Instrument OMY GB00B0381Z20 SYNAIRGEN PLC LS-,01 EQUITY wird ex Kapitalmassnahme gehandelt am 16.10.2020 The instrument OMY GB00B0381Z20 SYNAIRGEN PLC LS-,01 EQUITY is traded ex capital adju...
15.10.20 - 13:48
Synairgen Raises GBP80 Million In Placing, To Launch Open Offer (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
15.10.20 - 08:43
Synairgen successfully closes £80mln share sale to fund pivotal trial and manufacturing of breakthrough COVID-19 drug (Proactive Investors)
 
Synairgen PLC (LON:SNG) said it has successfully concluded an £80mln share placing, providing the financial backing to take its lead drug through final-stage clinical trials in patients with severe coronavirus (COVID-19). The cash will also be inves...
14.10.20 - 19:30
IN BRIEF: Synairgen Looks To Raise GBP80 Million For SNG001 Trial (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
29.09.20 - 16:37
Proactive news headlines: Synairgen, Westminster Group, Jersey Oil & Gas, Powerhouse Energy... (Proactive Investors)
 
Synairgen PLC (LON:SNG) has inked an agreement that will make available to patients an experimental drug that has shown early promise tackling the worst symptoms of the COVID-19. Ariana Resources PLC (LON:AAU) plans to pay a special dividend to share...
29.09.20 - 13:30
Synairgen Progresses Covid-19 Treatment As Expenses Increase (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
29.09.20 - 13:22
Synairgen plc reports 1H results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.09.20 - 09:14
Clinigen, Synairgen launch managed access program for medication to treat hospitalised Covid-19 patients (StockMarketWire)
 
Pharma group Clinigen and drug discovery and development company Synairgen signed an agreement to launch a managed access program for the latter's inhaled formulation medication to treat hospitalised COVID-19 patients. Synairgen had announced p...
29.09.20 - 09:02
Synairgen, Clinigen to launch access programme for Covid-19 treatment (StockMarketWire)
 
Respiratory drug focused Synairgen said it and pharmaceutical services company Clinigen had agreed to launch an access programme for a potential treatment for Covid-19. The managed access programme would be established for Synairgen's inhaled formul...
29.09.20 - 08:55
Synairgen teams up with Clinigen to provide a managed access programme for Covid treatment (Proactive Investors)
 
Synairgen PLC (LON:SNG) has inked an agreement that will make available to patients an experimental drug that has shown early promise tackling the worst symptoms of the COVID-19. The managed access programme for SNG001, an inhaled interferon-beta tre...
09.09.20 - 17:30
IN BRIEF: Synairgen Makes Inhaled Interferon Beta Patent Application (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
09.09.20 - 10:02
Synairgen submits patent application for inhaled COPD treatment (StockMarketWire)
 
Respiratory disease focused Synairgen said it had submitted a patent application for an inhaled treatment for virus-induced exacerbations in patients with chronic obstructive pulmonary disease Synairgen also had in July submitted a patent application...
09.09.20 - 09:37
Synairgen submits patent application for SNG001 treatment (Proactive Investors)
 
Synairgen PLC (LON:SNG) said it has submitted a patent application for its inhaled interferon beta asset, SNG001. The AIM-listed respiratory drug developer said it has submitted an application to use SNG001 to treat virus-induced exacerbations in pat...
08.09.20 - 21:00
IN BRIEF: Synairgen Reports Promising Findings From SNG001 Trial (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
>Zitat des Tages: Frau Venus, meine schöne Frau, // Von süßem Wein und Küssen, // Ist meine Seele geworden krank; // Ich schmachte nach Bitternissen. - Heinrich Heine
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter

Copyright @ Boersentreff.de - Die Märkte im Blick!